About Rob Fannon
Rob Fannon is the editor of Phase 1 Investor, a monthly conference-call service and investment advisory that covers the biotech industry and other small companies on the cutting edges of their industries. He later helped open a new biotechnology company in India and holds a master's degree in public health and an MBA from Johns Hopkins University. In February 2007, Rob launched The Medical Investor.
May 2nd, 2008 |
By Rob Fannon |
Category: US Dollar & Forex Trading
Back in December, my friend Steve Sjuggerud described a British spending spree taking place in America. At the time, the pound was worth about $1.95, and Brits were enjoying a 50% discount on their Christmas shopping across the pond.
Tags: Big pharma, Biotech Investors, Biotech Stocks, dollar, falling dollar, Glaxosmithkline, Great Science, GSK, pharma stocks, Sirtris Pharmaceuticals, Us Stock Market, Weak Dollar
Posted in US Dollar & Forex Trading |
No Comments »
Apr 5th, 2008 |
By Rob Fannon |
Category: Stock Market Investing
It’s no secret America’s health care system has problems. As I wrote last week, tens of thousands of people die unnecessarily every year due to medical errors… many of which could be prevented if hospitals and doctors adopted technology to track prescriptions and handle health care records.
Tags: , Health Care Information, Health Care System, Insurance Companies, Mck, Mckesson Corporation, Medical Errors, Medical Providers, Small Caps, Uk France, US stocks
Posted in Stock Market Investing |
No Comments »